Bradley Nardick

Founded by world-class researchers, clinicians, and thought leaders from Massachusetts General Hospital and Harvard University, Sensorium Therapeutics is a biotechnology company leveraging cutting-edge chemistry, neuroscience, and machine learning to develop nature-derived psychoactive medicines for mental health. Inspired by the real-world human benefits of plants and fungi, Sensorium’s groundbreaking Biodynamic Discovery Platform leverages cutting-edge chemistry, neuroscience, and machine learning to reproduce, adapt, and enhance targeted molecules to elevate their utility as modern medicines that can deliver transformational benefits to patients around the world. Visit sensorium.bio to learn more.

Simmer (YC W19) tells users what to order using AI. Simmer is now live in SF, DC, NYC and Chicago!

Optivolt is driving global energy abundance through breakthroughs in solar power electronics. The Problem: Despite its potential, solar supplies just 5% of global energy—limited by fundamental technical barriers. Minor shading can reduce power output by 90%, while systems remain bulky, expensive, time-consuming to install, and prone to failure. Optivolts Breakthrough: We realized deep integration between solar panels and power electronics unlocks an entirely new design space for innovation. This led us to inventing the Balancer (8 patents issued, 27 pending), an advanced power electronics device which embeds inside solar panels. Balancers work by shuffling power from stronger to weaker zones in the panel to keep power flowing, maximizing energy output and reliability. Performance vs. $8B market leader: • Up to 6x higher power output in real-world conditions • 40% lower equipment cost, 50% faster to install • 4x less failure points, while eliminating hotspots (#1 solar failure mode) Balancers cut the cost of solar by up to 40%, which for the first time, makes solar cheaper than the grid—everywhere. Recognizing the impact, the U.S. Department of Energy is participating in funding of Optivolt’s development.

Founded by world-class researchers, clinicians, and thought leaders from Massachusetts General Hospital and Harvard University, Sensorium Therapeutics is a biotechnology company leveraging cutting-edge chemistry, neuroscience, and machine learning to develop nature-derived psychoactive medicines for mental health. Inspired by the real-world human benefits of plants and fungi, Sensorium’s groundbreaking Biodynamic Discovery Platform leverages cutting-edge chemistry, neuroscience, and machine learning to reproduce, adapt, and enhance targeted molecules to elevate their utility as modern medicines that can deliver transformational benefits to patients around the world. Visit sensorium.bio to learn more.

Simmer (YC W19) tells users what to order using AI. Simmer is now live in SF, DC, NYC and Chicago!

Optivolt is driving global energy abundance through breakthroughs in solar power electronics. The Problem: Despite its potential, solar supplies just 5% of global energy—limited by fundamental technical barriers. Minor shading can reduce power output by 90%, while systems remain bulky, expensive, time-consuming to install, and prone to failure. Optivolts Breakthrough: We realized deep integration between solar panels and power electronics unlocks an entirely new design space for innovation. This led us to inventing the Balancer (8 patents issued, 27 pending), an advanced power electronics device which embeds inside solar panels. Balancers work by shuffling power from stronger to weaker zones in the panel to keep power flowing, maximizing energy output and reliability. Performance vs. $8B market leader: • Up to 6x higher power output in real-world conditions • 40% lower equipment cost, 50% faster to install • 4x less failure points, while eliminating hotspots (#1 solar failure mode) Balancers cut the cost of solar by up to 40%, which for the first time, makes solar cheaper than the grid—everywhere. Recognizing the impact, the U.S. Department of Energy is participating in funding of Optivolt’s development.

The Bazaar, Inc. is the leader in buying and distributing brand name wholesale merchandise closeouts. As a preferred liquidation partner for over 60 years, big-box retailers and major multinational consumer goods manufacturers place their trust in us to acquire their overstock and returns, turning excess, out-of-date inventory and cancelled orders into cash flow. This allows us to provide our independent retail and ecommerce clients with name brand food, health and beauty, sporting goods, housewares, household goods, school supplies, books and soft and seasonal goods at below market cost. We buy, sell and ship millions of pieces of merchandise every year from our 400,000 sq ft warehouse, physical locations and online and retail stores called Bargains in a Box. Our efficient reverse logistics systems, distribution models, and intense attention to detail in adhering to the requirements of each individual brand has helped The Bazaar forge deep multi-year relationships with the worlds most trusted household names. Some of our partners include SC Johnson, Energizer, Unilever, 3M, Pfizer, Mattel, TeleBrands, Medline, Glaxo Smith Klein, Fruit of the Loom, GE, and many more. The Bazaar is a third-generation family business that embraces a ‘People-First’ mentality to create meaningful connections with our team members, clients, and customers that drives value beyond the transaction. Its Inclusion Program is a celebrated pillar of the company culture, earning numerous awards and recognition — including Most Innovative Business for Inclusive Hiring in 2021 by the Illinois Department of Human Services — for contributions in supporting people with disabilities. For more information about The Bazaar, Inc., visit www.thebazaarinc.com.